🇺🇸 FDA
Patent

US 6455541

Suppression, by 5-lipoxygenase inhibitors, of bone resorption

expired A61KA61K31/00A61K31/05

Quick answer

US patent 6455541 (Suppression, by 5-lipoxygenase inhibitors, of bone resorption) held by The Board of Regents of the University of Texas System expires Mon Sep 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 24 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/00, A61K31/05, A61K31/405, A61K31/47